Medtronic plc (MDT) · Insider Trading (Form 4) SEC Filing

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-05-26 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Medtronic plc (MDT) CIK: 0001613103 --- Reporting Owner --- Name: KIIL HARRY SKIP CIK: 0001708062 Role: Officer (EVP & President Cardiovascular) --- Non-Derivative Transactions --- [Transaction #1] Security: Ordinary Shares Date: 2026-05-26 | Code: M (Exercise of derivative) Shares: +15,195 | Price: $0.00 Shares Owned After: 48,233 | Ownership: D (Direct) Footnotes: [F1] Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026. [F2] Includes 270 shares acquired through dividend reinvestment since the last report filed by the reporting person. --- Derivative Transactions --- [Transaction #1] Security: Performance Share Unit Date: 2026-05-26 | Code: M (Exercise of derivative) Shares: -14,517 | Price: $0.00 Shares Owned After: 0 | Ownership: D (Direct) Footnotes: [F3] Each performance share unit represents a contingent right to receive one share of Medtronic common stock. [F4] The performance share units vested on April 24, 2026. [F4] The performance share units vested on April 24, 2026. --- Footnotes (Complete Index) --- F1: Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026. F2: Includes 270 shares acquired through dividend reinvestment since the last report filed by the reporting person. F3: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4: The performance share units vested on April 24, 2026. --- Signature --- /s/ /s/ Patricia Walesiewicz, attorney-in-fact (2026-05-28)